Document is current

Any future updates will be listed below

Correction: Preferences of patients with high-risk HR+/HER2− breast cancer for adjuvant endocrine treatment: an adaptive choice-based conjoint analysis study from Germany

Crossref DOI link: https://doi.org/10.1007/s10549-025-07677-8

Published Online: 2025-03-15

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark